"Myelophrenia": its contribution to the management of aplastic anemia.
D000728:Androgens / Q000627:therapeutic use; D000741:Anemia, Aplastic / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001853:Bone Marrow / Q000503:physiopathology*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D006412:Hematopoietic Stem Cells / Q000473:pathology / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy; D013601:T-Lymphocytes / Q000276:immunology
D000728:Androgens; D000961:Antilymphocyte Serum